🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Service Response and Material Elimination

According to the social media company, the platform has removed violative material and prohibited associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, populated with images of weight loss, glowing reviews and step-by-step guides for mixing or administering at residence.

After minutes of entering one community, a seller shared WhatsApp details, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.

Product Details and Costs

Inside these communities, messages show dark colored packages with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram said it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has already encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially significant health risks”.